Keyes Stange & Wooten Wealth Management’s Medtronic MDT Stock Holding History

Keyes Stange & Wooten Wealth Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-7,046	Closed	-$677K	–	73
2025 Q4	$677K	Sell	7,046 -340	-5%	-$33K	0.32%	30
2025 Q3	$703K	Sell	7,386 -114	-2%	-$10.5K	0.34%	32
2025 Q2	$654K	Sell	7,500 -400	-5%	-$33.9K	0.34%	35
2025 Q1	$710K	Buy	7,900 +159	+2%	+$14.2K	0.4%	32
2024 Q4	$618K	Sell	7,741 -94	-1%	-$8.14K	0.36%	33
2024 Q3	$705K	Buy	7,835 +435	+6%	+$36.6K	0.42%	34
2024 Q2	$582K	Buy	7,400 +252	+4%	+$20.7K	0.41%	35
2024 Q1	$623K	Buy	7,148 +374	+6%	+$31.9K	0.55%	32
2023 Q4	$558K	Buy	+6,774	New	+$516K	0.59%	31

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Keyes Stange & Wooten Wealth Management's MDT Position: Q1 2026 in Review

Keyes Stange & Wooten Wealth Management sold out of Medtronic (MDT) in Q1 2026, closing a stake of 7,046 shares — an estimated $677K sold.

Keyes Stange & Wooten Wealth Management first reported a position in MDT in Q4 2023 and held it in 9 quarters. The position peaked at $710K in Q1 2025. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

Keyes Stange & Wooten Wealth Management reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
Keyes Stange & Wooten Wealth Management sold 7,046 Medtronic shares in Q1 2026, an estimated $677K.
Keyes Stange & Wooten Wealth Management first reported a position in Medtronic in Q4 2023 and held it in 9 quarters.
Keyes Stange & Wooten Wealth Management's Medtronic position peaked at $710K in Q1 2025.
2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Keyes Stange & Wooten Wealth Management's 13F filing for Q1 2026, filed 27 Apr 2026.